Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | March 05, 2025 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 3VYF | P00797 | Human renin in complex with inhibitor 9 | |
| 4AMT | P00797 | Crystal structure at 2.6A of human prorenin | |
| 4GJ5 | P00797 | Crystal structure of renin in complex with NVP-AMQ838 (compound 5) | |
| 4GJ6 | P00797 | Crystal structure of renin in complex with NVP-AYZ832 (compound 6a) | |
| 4GJ7 | P00797 | Crystal structure of renin in complex with NVP-BCA079 (compound 12a) | |
| 4GJ8 | P00797 | Crystal structure of renin in complex with PKF909-724 (compound 3) | |
| 4GJ9 | P00797 | Crystal structure of renin in complex with GP055321 (compound 4) | |
| 4GJA | P00797 | Crystal structure of renin in complex with NVP-AYL747 (compound 5) | |
| 4GJB | P00797 | Crystal structure of renin in complex with NVP-BBV031 (compound 6) | |
| 4GJC | P00797 | Crystal structure of renin in complex with NVP-BCH965 (compound 9) | |
| 4GJD | P00797 | Crystal structure of renin in complex with NVP-BGQ311 (compound 12) | |
| 4PYV | P00797 | Crystal structure of renin in complex with compound4 | |
| 4Q1N | P00797 | Structure-based design of 4-hydroxy-3,5-substituted piperidines as direct renin inhibitors | |
| 4RYC | P00797 | RENIN IN COMPLEXED WITH 4-methoxy-3-(3-methoxypropoxy)-N-{[(3S,4S)-4-{[(4-methylphenyl)sulfonyl]amino}pyrrolidin-3-yl]methyl}-N-(propan-2-yl)benzamide INHIBITOR | |
| 4RYG | P00797 | RENIN IN COMPLEXED WITH N-({(3S,4S)-4-[(benzylsulfonyl)amino]pyrrolidin-3-yl}methyl)-4-methoxy-3-(3-methoxypropoxy)-N-(propan-2-yl)benzamide INHIBITOR | |
| 4RZ1 | P00797 | RENIN IN COMPLEXED WITH (3S,4S)-4-({[4-methoxy-3-(3-methoxypropoxy)benzoyl](propan-2-yl)amino}methyl)pyrrolidin-3-yl benzylcarbamate INHIBITOR | |
| 4S1G | P00797 | Renin in complex with (S)-1-(3-fluoro-5-(((S)-1-phenylethyl)carbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1H)-iminium | |
| 4XX3 | P00797 | Renin in complex with (S)-1-(3-(benzylcarbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1H)-iminium | |
| 4XX4 | P00797 | Renin in complex with (4S)-4-isopropyl-4-methyl-6-oxo-1-(3-(2-oxo-4-phenylpyrrolidin-1-yl)benzyl)tetrahydropyrimidin-2(1H)-iminium | |
| 5KOQ | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | |
| 5KOS | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | |
| 5KOT | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | |
| 7XGK | P00797 | Human renin in complex with compound1 | |
| 7XGO | P00797 | Human renin in complex with compound2 | |
| 7XGP | P00797 | Human renin in complex with compound3 | |
| 1APT | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION | |
| 1APU | P00798 | Crystallographic analysis of a pepstatin analogue binding to the aspartyl proteinase penicillopepsin at 1.8 angstroms resolution | |
| 1APV | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH A TETRAHEDRAL TRANSITION STATE MIMIC INHIBITOR: ISOVALERYL (IVA)-VAL-VAL-HYDRATED DIFLUOROSTATONE-N-METHYLAMINE |
| 1APW | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH A TETRAHEDRAL TRANSITION STATE MIMIC INHIBITOR: ISOVALERYL (IVA)-VAL-VAL-DIFLUOROSTATINE-N-METHYLAMINE |
| 1BXO | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL CYCLO[(2S)-2-[[(1R)-1-(N-(L-N-(3-METHYLBUTANOYL)VALYL-L-ASPARTYL)AMINO)-3-METHYLBUT YL] HYDROXYPHOSPHINYLOXY]-3-(3-AMINOMETHYL) PHENYLPROPANOATE | |
| 1BXQ | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR. | |
| 1PPK | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHOROUS-CONTAINING PEPTIDE ANALOGUES | |
| 1PPL | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES | |
| 1PPM | P00798 | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES | |
| 2WEA | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT | |
| 2WEB | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L-VALYL)AMINO-2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT | |
| 2WEC | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1-NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT | |
| 2WED | P00798 | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT | |
| 2ASI | P00799 | ASPARTIC PROTEINASE | |
| 2RMP | P00799 | RMP-pepstatin A complex | |
| 6D5P | P00800 | Hexagonal thermolysin cryocooled to 100 K with 20% xylose as cryoprotectant | |
| 6N4W | P00800 | Tetragonal thermolysin (with 50% xylose) cryocooled in a nitrogen gas stream to 100 K | |
| 6D5R | P00800 | Hexagonal thermolysin cryocooled to 100 K with 50% xylose as cryoprotectant | |
| 6D5Q | P00800 | Hexagonal thermolysin cryocooled to 100 K with 30% xylose as cryoprotectant | |
| 5UN3 | P00800 | Tetragonal thermolysin (295 K) in the presence of 50% xylose | |
| 5UU8 | P00800 | Tetragonal thermolysin cryocooled to 100 K with 30% xylose as cryoprotectant | |
| 5UU9 | P00800 | Tetragonal thermolysin cryocooled to 100 K with 40% xylose as cryoprotectant | |
| 5UUA | P00800 | Tetragonal thermolysin cryocooled to 100 K with 50% xylose as cryoprotectant | |
| 5UUB | P00800 | Tetragonal thermolysin cryocooled to 100 K with 25% xylose/25% mpd as cryoprotectant | |
| 6D5N | P00800 | Hexagonal thermolysin (295) in the presence of 50% xylose |
